Thumb img 20171101 154706 514

Jeff Stevens

active 8 days ago

Toronto, ON

  • remove_red_eye44 Profile views
  • tag_faces462
  • supervisor_account12 Connections
  • description116 Posts

Public Company Officer & Director, Deal Originator & Capital Markets Professional. President and COO of Datametrex AI Limited (TSXV:DM) Director of Dawson Gold (TSXV:DYU)

Company Associations
image
President and COO @ Datametrex AI Limited

Jeff brings over 18 years of professional experience in the Canadian Capital Markets, largely focusing on raising capital for micro-cap and small cap companies. He currently sits on the board of two public companies assisting with project selection and financing. He has worked on the Retail, Buy, and Sell sides of the industry, having held positions as Assistant Investment Advisor, Arbitrage Trader, as well as having been the head of two Sales and Trading desks for a US-based investment bank in Toronto. During his tenure Jeff was involved in raising in excess of $500M for public and private companies with a client base including Institutional Money Managers, Hedge Funds, Mutual Funds and Family Offices in Canada, US and Europe

Thumb img 20171101 154706 514

@JEFF STEVENS

active 8 days ago

Toronto, ON

Company Associations
image
President and COO @ Datametrex AI Limited

Jeff brings over 18 years of professional experience in the Canadian Capital Markets, largely focusing on raising capital for micro-cap and small cap companies. He currently sits on the board of two public companies assisting with project selection and financing. He has worked on the Retail, Buy, and Sell sides of the industry, having held positions as Assistant Investment Advisor, Arbitrage Trader, as well as having been the head of two Sales and Trading desks for a US-based investment bank in Toronto. During his tenure Jeff was involved in raising in excess of $500M for public and private companies with a client base including Institutional Money Managers, Hedge Funds, Mutual Funds and Family Offices in Canada, US and Europe

Groups (6)
  • Datametrex AI Limited

    Public Group

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence a......

    347

  • Dreamfield Education Ltd

    Private Group

    Dreamfield Education Ltd. facilitates North American language and learning opportunities to posts......

    41

  • Cielo Waste Solutions Corp.

    Public Group

    We specialize in environmentally advanced technologies focused on materials recovery, renewable d......

    132

  • Graph Blockchain Limited

    Public Group

    Graph Blockchain Limited develops bleeding-edge customized private BlockChain solutions – with a ......

    105

  • Global UAV Technologies, Ltd.

    Public Group

    Global UAV Technologies will continue its growth through expanding the business of its current su......

    107

  • Revive Therapeutics Ltd.

    Private Group

    Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) (FSE: 31R) is a specialty cannabis company f......

    10

Groups 6
  • image

    Datametrex AI Limited

    Public Group

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence a......

    347

  • image

    Dreamfield Education Ltd

    Private Group

    Dreamfield Education Ltd. facilitates North American language and learning opportunities to posts......

    41

Companies Following (1)
  • image
    Investor Group
    Technology
    $
    0.00-

    Datametrex AI Limited Active 1 day

    people 347 Members - Public

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Blockchain sol... ...

    Corporate Profile Press Releases

Companies Following (1)
  • image
    Investor Group
    Technology
    $
    0.00-

    Datametrex AI Limited Active 1 day

    people 347 Members - Public

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Blockchain sol... ...

    Corporate Profile Press Releases

Thumb img 20171101 154706 514

Jeff Stevens

active 8 days ago

Toronto, ON

  • remove_red_eye44 Profile views
  • tag_faces462
  • supervisor_account12 Connections
  • description116 Posts

Public Company Officer & Director, Deal Originator & Capital Markets Professional. President and COO of Datametrex AI Limited (TSXV:DM) Director of Dawson Gold (TSXV:DYU)

Company Associations
image
President and COO @ Datametrex AI Limited

Jeff brings over 18 years of professional experience in the Canadian Capital Markets, largely focusing on raising capital for micro-cap and small cap companies. He currently sits on the board of two public companies assisting with project selection and financing. He has worked on the Retail, Buy, and Sell sides of the industry, having held positions as Assistant Investment Advisor, Arbitrage Trader, as well as having been the head of two Sales and Trading desks for a US-based investment bank in Toronto. During his tenure Jeff was involved in raising in excess of $500M for public and private companies with a client base including Institutional Money Managers, Hedge Funds, Mutual Funds and Family Offices in Canada, US and Europe

Thumb img 20171101 154706 514

@JEFF STEVENS

active 8 days ago

Toronto, ON

Company Associations
image
President and COO @ Datametrex AI Limited

Jeff brings over 18 years of professional experience in the Canadian Capital Markets, largely focusing on raising capital for micro-cap and small cap companies. He currently sits on the board of two public companies assisting with project selection and financing. He has worked on the Retail, Buy, and Sell sides of the industry, having held positions as Assistant Investment Advisor, Arbitrage Trader, as well as having been the head of two Sales and Trading desks for a US-based investment bank in Toronto. During his tenure Jeff was involved in raising in excess of $500M for public and private companies with a client base including Institutional Money Managers, Hedge Funds, Mutual Funds and Family Offices in Canada, US and Europe

Groups (6)
  • Datametrex AI Limited

    Public Group

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence a......

    347

  • Dreamfield Education Ltd

    Private Group

    Dreamfield Education Ltd. facilitates North American language and learning opportunities to posts......

    41

  • Cielo Waste Solutions Corp.

    Public Group

    We specialize in environmentally advanced technologies focused on materials recovery, renewable d......

    132

  • Graph Blockchain Limited

    Public Group

    Graph Blockchain Limited develops bleeding-edge customized private BlockChain solutions – with a ......

    105

  • Global UAV Technologies, Ltd.

    Public Group

    Global UAV Technologies will continue its growth through expanding the business of its current su......

    107

  • Revive Therapeutics Ltd.

    Private Group

    Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) (FSE: 31R) is a specialty cannabis company f......

    10

Groups 6
  • image

    Datametrex AI Limited

    Public Group

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence a......

    347

  • image

    Dreamfield Education Ltd

    Private Group

    Dreamfield Education Ltd. facilitates North American language and learning opportunities to posts......

    41

Companies Following (1)
  • image
    Investor Group
    Technology
    $
    0.00-

    Datametrex AI Limited Active 1 day

    people 347 Members - Public

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Blockchain sol... ...

    Corporate Profile Press Releases

Companies Following (1)
  • image
    Investor Group
    Technology
    $
    0.00-

    Datametrex AI Limited Active 1 day

    people 347 Members - Public

    Datametrex AI Limited is a technology focused company with exposure to: Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Blockchain sol... ...

    Corporate Profile Press Releases

Recent Group Activity

Deshaies, thanks for reaching out. The Hyundai contract DM announced with IBM was for Graph Blockchain, at the time, Graph was still a JV company under the DM umbrella and as such the press release came from DM. On May 25, 2018 DM announced its first contract with Hyundai but this was not through IBM. Graph has signed multiple agreements with multinational clients including Hyundai, Samsung and LG some directly with our sales team network and some through its relationship with IBM. I hope this helps.
keyboard_arrow_downShow Post

!

Jean-Raymond, Deshaies posted an update in DATAMETREX AI LIMITED

Hi Jeff, Correct me if I am wrong. By memory DM had an agreement with IBM. DM was negociating with Hyundai... And now IBM has signed a deal with Hyundai... Is DM part of this deal? Thanks

!
Thumb img 20171101 154706 514

Jeff Stevens commented on Michel Durieux  update in DATAMETREX AI LIMITED

8 days

Thanks Michel, I will share the link with the team at Nexalogy. As you know, we were granted vendor status to sell to the US government, now that they are open for business the team is working hard to get some traction.
keyboard_arrow_downShow Post

!
Thumb img 20171101 154706 514

Jeff Stevens commented on William Stronghold  update in DATAMETREX AI LIMITED

10 days

!

William Stronghold posted an update in DATAMETREX AI LIMITED

Jeff, is your Q3 date July 1st? I think investors and potential investors would be elated if you could have this ready well in advance of the Canadian Federal election. Could be hard to penetrate the US government without some proven track record. I'm basically curious about the actual anticipate readiness for the Fake News Filter.

!
Thumb img 20171101 154706 514

Jeff Stevens commented on William Stronghold  update in DATAMETREX AI LIMITED

10 days

William, appreciate the excitement. We will have the product built for our client in advance of Q3. We will then work to have it commercially available for the general audience by Q3. As you know, we have been selling our solutions to various Canadian Federal government agencies for 3+ years...track record is there and that is why we were recently approved to be a vendor to the US government. Hope this helps. Thanks
keyboard_arrow_downShow Post

!

William Stronghold posted an update in DATAMETREX AI LIMITED

Jeff, is your Q3 date July 1st? I think investors and potential investors would be elated if you could have this ready well in advance of the Canadian Federal election. Could be hard to penetrate the US government without some proven track record. I'm basically curious about the actual anticipate readiness for the Fake News Filter.

!
Thumb img 20171101 154706 514

Jeff Stevens posted an update in DATAMETREX AI LIMITED

10 days

When we look at major themes in the media, we can't help but feel very well positioned with our Fake News Filter, which we are on track to have commercially available for Q3 of the this year. Each week we continue to read articles (like the attached) discussing the need to identify individuals/groups that are attempting to influence events and conversations to create divides in our country via fake news on social media. Our team is working diligently to ensure we are part of the solution in Canada and now that the US is open for business, we are keen to pick up conversations south of the border. We view this as a global opportunity for DM.

https://www.theglobeandmail.com/opinion/article-canadas-plan-to-counter-foreign-interference-is-a-good-start-but-the/

!
Thumb img 20171101 154706 514

Jeff Stevens commented on Jeff Stevens  update in DATAMETREX AI LIMITED

14 days

Thanks for the comments Michel. We are working towards having the Fake News Filter commercially available by Q3 2019. Our team is working diligently and we are pushing to get it out on time. In my opinion, it is a exciting development for us, we are currently able to work in French, English, Russian, Spanish, Japanese, Korean and Mandarin. We have the ability to take on many more languages as we grow and the interest is there.
keyboard_arrow_downShow Post

!
Thumb img 20171101 154706 514

Jeff Stevens commented on William Stronghold  update in DATAMETREX AI LIMITED

15 days

Hi William, thanks for reaching out. Marshall is not the successor to Claude. From the time Datametrex acquired Nexalogy, Andrew Ryu has been the CEO of Nexalogy. Marshall taking on the CEO role did not affect or change Claude's position in the company at all. Claude has always reported to a CEO. Datametrex felt it would benefit Nexalogy to have the role in house in Montreal. Given Marshall's track record and experience managing teams and growing businesses we felt it was a good fit.
keyboard_arrow_downShow Post

!

William Stronghold posted an update in DATAMETREX AI LIMITED

Jeff, was Marshall Gunter originally hired as the successor to Claude?

!
Thumb img 20171101 154706 514

Jeff Stevens replied to the press release 8020 Admin  update in DATAMETREX AI LIMITED

15 days

...

Syed, thanks for reaching out. As you know, management changes are a natural part of a companies growth. We are sorry to see Claude depart and thank him for all his contributions to Nexalogy over the years. Fortunately, we have a great team in place that can keep pace with the workload under the leadership of our new CEO, Marshall Gunter. We believe this next chapter for Nexalogy will be an exciting time as we continue to execute on opening new markets and diversifying the companies product offerings. Thanks - Jeffkeyboard_arrow_downShow Post

!
Thumb 8020 monitor 200 200  png

8020 Admin

15 days

8020 Admin  posted an update in DATAMETREX AI LIMITED

TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) announces that it has ended its previously-announced non-brokered private placement (the “Offering”) of units (each a “Unit”) and that no further tranches will be completed. An aggregate of 22,044,000 Units at a price of $0.05 per Unit were sold under a single tranche on January 25, 2019 for aggregate gross proceeds of $1,102,200.


Each Unit consisted of one common share in the capital of the Company and one common share purchase warrant, with each warrant exercisable into one common share at a price of $0.08 for a period of 18 months after closing of the Offering (the “Warrant Expiry Date”). In the event that the volume-weighted average trading price of the common shares on the TSX Venture Exchange equals or exceeds $0.12 per common share for any period of 15 consecutive trading days, the Company may, at its option, within 10 business days following such 15-day period, accelerate the Warrant Expiry Date by issuing a press release (a “Warrant Acceleration Press Release”), and, in such case, the Warrant Expiry Date shall be deemed to be 5:00 p.m. (Toronto time) on the 15th day following the issuance of the Warrant Acceleration Press Release. The Company intends to use the aggregate net proceeds of the Offering for research and development and general working capital purposes.


Although the Offering was non-brokered, the Company compensated a dealer that introduced subscribers to the Company (a “Finder”) by way of: (i) a cash finder’s fee equal to 8% of the aggregate gross proceeds of the subscribers introduced to the Company by such Finder; and (ii) 564,800 non-transferable common share purchase warrants (on terms identical to those warrants under the Offering), representing 8% of the aggregate Units of the subscribers introduced to the Company by such Finder.


The securities issued in connection with this first tranche of the Offering, including the Finder’s warrants, are subject to a four-month hold period ending on May 26, 2019. Certain insiders of the Company participated in the first tranche of the Offering and purchased an aggregate of $545,000 (10,900,000 Units), which includes $300,000 (6,000,000 Units) from Andrew Ryu, CEO of the Company, and $120,000 (2,400,000 Units) from Jeffrey Stevens, President and COO of the Company. Participation of such insiders in the Offering constituted a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”), but was exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities issued to the insider nor the consideration paid by the insider exceeded 25% of the Company’s market capitalization. None of the Company’s directors expressed any contrary views or disagreements with respect to the foregoing. The Company did not file a material change report 21 days prior to the closing of the Offering as the details of the participation of insiders of the Company had not been confirmed at that time.


Datametrex also announces that Claude Théoret has resigned as President and a director of Nexalogy Environics (“Nexalogy”), a subsidiary of the Company. Marshall Gunter, CEO of Nexalogy, will assume Mr. Théoret’s former responsibilities.


About Datametrex


Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com) and  Implementing Blockchain technology for secure Data Transfers through its investee company, Graph Blockchain (www.graphblockchain.com).


Additional information on Datametrex is available at: www.datametrex.com


For further information, please contact:


Jeffrey Stevens – President & COO
Phone: (647) 400-8494
Email: jstevens@datametrex.com


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Forward-Looking Statements


This press release contains "forward-looking information" within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.


The forward-looking information contained in this press release includes information relating to the potential acceleration of the Warrant Expiry Date and the use of the net proceeds of the Offering. Forward-looking information is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.


By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation, those discussed in the Company's current MD&A and Annual Information Form, both of which have been filed on SEDAR and can be accessed at www.sedar.com.


Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.


 


!
Thumb img 20171101 154706 514

Jeff Stevens replied to the press release 8020 Admin  update in DATAMETREX AI LIMITED

17 days

...

We are excited to partner with Empower on this pilot program. This will give us exposure to the US Cannabis market, specifically on clinical data for medical treatment. The US will be the largest market and getting in at this stage is key to positioning the company for growth. We look forward to working with Empower on this pilot and expanding the scope once completed. Thanks - Jeff keyboard_arrow_downShow Post

!
Thumb 8020 monitor 200 200  png

8020 Admin

17 days

8020 Admin  posted an update in DATAMETREX AI LIMITED

TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Datametrex AI Limited (TSXV:DM) (the “Company” or “Datametrex”) is pleased to announce its agreement to partner with EMPOWER CLINICS INC. (CSE: EPW) (“Empower”) through its subsidiary Canntop AI Inc. (“Canntop”) on the creation of a pilot program (“Pilot”) using Artificial Intelligence (“AI”) to analyze and gain insights about Empower patient data, physician treatment recommendations and overall long-term efficacy of patient care. This is to identify improvements and efficacy in long-term patient care.


Empower intends to use Canntop’s AI platform to gain actionable insights on how consumer social data is generating nationwide interest in CBD based products, alternative pain management options and the use of cannabis-based therapies.


The initial pilot will utilize Empower patient data in a HIPAA compliant manner, to determine if normalized data can be generated using Datametrex AI solutions to understand how patient care and efficacy of physician guided treatment recommendations are positively impacting serious qualifying conditions of patients.


“We believe using AI tools to analyze the substantial amounts of data in the Empower database and the additional data from the recently announced proposed Sun Valley acquisition can make Empower a data science leader in the Cannabis industry,” said Steven McAuley, Empower’s Chairman & CEO. He further states, “The outcomes of our AI efforts with Datametrex are definitely going to position the Company as an educational leader and we plan to collaborate with the industry to ultimately improve patient care.”


“Datametrex has already utilized its Nexalogy AI solution for Health Canada studies in the Cannabis sector to understand consumer usage and patterns based on massive social insights generated through social media channels,” said Jeffrey Stevens, Datametrex President & COO. “We believe an AI pilot with Empower has the potential to provide disruptive insights that alternative care options can provide people around the world.”


ABOUT EMPOWER


Empower is undertaking new growth initiatives to be positioned as a vertically integrated diverse health and wellness company with an expanding network of physician-staffed clinics, a diverse CBD product strategy and a leader in hemp-derived CBD extraction, research and development. Treatment solutions are focused on education, data and efficacy in combination with other modalities to support patients with serious qualifying conditions, such as chronic pain, PTSD, sleep disorders, opioid dependency, epilepsy and more. It is expected that Empower's proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based product options in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine and an expanded product development strategy, Empower is ready to capitalize on the explosive growth expectations in the United States after the passing of US$867 billion Agriculture Improvement Act (the Farm Bill).


About Datametrex


Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiaries, Nexalogy (www.nexalogy.com) and Canntop AI (www.canntop.com) and Implementing Blockchain technology for secure Data Transfers through its investee company, Graph Blockchain (www.graphblockchain.com).


Additional information on Datametrex is available at: www.datametrex.com


For further information, please contact:


Jeffrey Stevens – President & COO
Phone: (647) 400-8494
Email: jstevens@datametrex.com


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Forward-Looking Statements


This news release contains "forward-looking information" within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy.


By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation, those discussed in the Company's current MD&A and Annual Information Form, both of which have been filed on SEDAR and can be accessed at www.sedar.com.


Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

!